Encouragingly, Angelica sinensis polysaccharides exhibited promise in reducing acetylcholinesterase (AChE) levels, elevating acetylcholine (ACh) and choline acetyltransferase (ChAT) levels, and improving memory impairment in AD rats through the BDNF/CREB pathway (43). Here, BDNF is linked to Alzheimer disease.